Sievers, P., Uhlmann, L., Korkmaz-İçöz, S., Fastner, C., Bea, F., Blessing, E., . . . Preusch, M. (2015). Combined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis. Drug design, development and therapy, 9, . https://doi.org/10.2147/DDDT.S85203
Chicago-Zitierstil (17. Ausg.)Sievers, Philipp, Lorenz Uhlmann, Sevil Korkmaz-İçöz, Christian Fastner, Florian Bea, Erwin Blessing, Hugo Katus, und Michael Preusch. "Combined Treatment with Olmesartan Medoxomil and Amlodipine Besylate Attenuates Atherosclerotic Lesion Progression in a Model of Advanced Atherosclerosis." Drug Design, Development and Therapy 9 (2015). https://doi.org/10.2147/DDDT.S85203.
MLA-Zitierstil (9. Ausg.)Sievers, Philipp, et al. "Combined Treatment with Olmesartan Medoxomil and Amlodipine Besylate Attenuates Atherosclerotic Lesion Progression in a Model of Advanced Atherosclerosis." Drug Design, Development and Therapy, vol. 9, 2015, https://doi.org/10.2147/DDDT.S85203.